Breast cancer: Early- and late-fluorescence near-infrared imaging with indocyanine green - A preliminary study

Radiology

Volumn 258, Issue 2, 2011, Pages 409-416

  Poellinger, Alexander ^a   Burock, Susen ^a   Grosenick, Dirk ^b   Hagen, Axel ^b   Lüdemann, Lutz ^a   Diekmann, Felix ^a   Engelken, Florian ^a   Macdonald, Rainer ^b   Rinneberg, Herbert ^b   Schlag, Peter Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; IMAGE QUALITY; MAMMOGRAPHY; NEAR INFRARED DIFFUSE OPTICAL MAMMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; VISIBILITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INDOCYANINE GREEN; MAMMOGRAPHY; MIDDLE AGED; SPECTROSCOPY, NEAR-INFRARED; STATISTICS, NONPARAMETRIC;

EID: 79952149983     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100258     Document Type: Article

References (22)

1. Tromberg BJ, Shah N, Lanning R, et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000;2(1-2):26-40. (Pubitemid 30123178)
2. Taroni P, Torricelli A, Spinelli L, et al. Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 2005;50(11):2469-2488. (Pubitemid 40770634)
3. Poplack SP, Tosteson TD, Wells WA, et al. Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. Radiology 2007;243(2):350-359. (Pubitemid 46649689)
4. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006;11(4):044005.
5. Grosenick D, Moesta KT, Möller M, et al. Time-domain scanning optical mammography. I. Recording and assessment of mammograms of 154 patients. Phys Med Biol 2005;50(11):2429-2449.
6. Choe R, Corlu A, Lee K, et al. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005;32(4):1128-1139. (Pubitemid 40586797)
7. Cerussi A, Hsiang D, Shah N, et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 2007;104(10):4014-4019. (Pubitemid 47181570)
8. Floery D, Helbich TH, Riedl CC, et al. Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 2005;40(6):328-335. (Pubitemid 40734560)
9. Rinneberg H, Grosenick D, Moesta KT, et al. Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo. Technol Cancer Res Treat 2005;4(5):483-496. (Pubitemid 41446802)
10. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000;97(6):2767-2772. (Pubitemid 30159246)
11. Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B. In vivo continuous-wave optical breast imaging enhanced with indocyanine green. Med Phys 2003;30(6):1039-1047.
12. Corlu A, Choe R, Durduran T, et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express 2007;15(11):6696-6716. (Pubitemid 46827669)
13. van de Ven S, Wiethoff A, Nielsen T, et al. A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol 2010;12(3):343-348.
14. Yoneya S, Saito T, Komatsu Y, Koyama I, Takahashi K, Duvoll-Young J. Binding properties of indocyanine green in human blood. Invest Ophthalmol Vis Sci 1998;39(7):1286-1290. (Pubitemid 28247368)
15. Hagen A, Grosenick D, Macdonald R, et al. Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions. Opt Express 2009;17(19):17016-17033.
16. Hagen A, Steinkellner O, Grosenick D, et al. Development of a multi-channel time-domain fluorescence mammograph. Proc SPIE 2007;6434:64340Z.
17. Paumgartner P, Probst P, Kraines R, Leevy CM. Kinetics of indocyanine green removal from the blood. Ann N Y Acad Sci 1970;170:134-147.
18. Ott P, Weisiger RA. Nontraditional effects of protein binding and hematocrit on uptake of indocyanine green by perfused rat liver. Am J Physiol 1997;273:G227-G238.
19. Sauda K, Imasaka T, Ishibashi N. Determination of protein in human serum by highperformance liquid chromatography with semiconductor laser fluorometric detection. Anal Chem 1986;58(13):2649-2653. (Pubitemid 17464329)
20. Desser TS, Rubin DL, Muller HH, et al. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight. J Magn Reson Imaging 1994;4(3):467-472.
21. Daldrup-Link HE, Brasch RC. Macromolecular contrast agents for MR mammography: current status. Eur Radiol 2003;13(2):354-365. (Pubitemid 36798614)
22. Dvorak HF. Vascular permeability to plasma, plasma proteins, and cells: an update. Curr Opin Hematol 2010;17(3):225-229.